Case Study: Regression of a Residual Tumor and Prolongation of Overall Survival
with Allergen-removed <i>Rhus verniciflua</i> Stokes after Chemoradiotherapy in Locally
Advanced Non-small Cell Lung Cancer

Kim, Kyung-suk

The Journal of Internal Korean Medicine > Volume 36(2); 2015 > Article

Article

The Journal of Internal Korean Medicine 2015;36(2): 200-206.

옻나무추출물 위주의 한방치료로 국소 진행된 비소세포폐암 환자의 잔존 종양의 관해와 생존기간이 연장된 사례

김경석

단국대학교 대학원 생명융합학과

Case Study: Regression of a Residual Tumor and Prolongation of Overall Survival with Allergen-removed Rhus verniciflua Stokes after Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer

Kyung-suk Kim

Dept. of Medical Consilience, Graduate School of Dan-Kook University

Correspondence

Kyung-suk Kim ,Tel: +82-31-260-5700, Fax: +82-31-260-5709, Email: dream01@hanafos.com

Received: May 27, 2015, Accepted: June 26, 2015, Published online: June 30, 2015.

ABSTRACT

Objectives:
The purpose of this study is to report the possibility of treatment of locally advanced non-small cell lung cancer with Traditional Korean Medicine based allergen-removed Rhus verniciflua Stokes (ARVS) following chemoradiotherapy.

Methods:
A patient with locally advanced non-small cell lung cancer (stage IIIB) felt chest discomfort, fatigue, and anxiety after chemoradiotherapy. To prevent recurrence, he opted to receive Traditional Korean Medicine.

Results:
After treatment with ARVS, the size of the residual primary cancer and a metastatic lymph node decreased, without new cancerous regions. The patient has maintained good performance and has shown prolonged overall survival.

Conclusions:
This report suggests that ARVS may play a therapeutic role in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy. Further studies will be needed to determine the effect of ARVS on locally-advanced unresectable non-small cell lung cancer.

Key words: allergen-removed Rhus verniciflua Stokes, aRVS, locally advanced non-small cell lung cancer, chemoradiotherapy